Top Story

Gastrointestinal, lung, breast and thyroid were other primary cancers associated with melanoma

November 24, 2015

Gastrointestinal cancer was the most common other primary systemic cancer in patients with melanoma, according to recently published study results.

Researchers conducted statistical analyses of primary cancers in 452 patients (mean age, 64.4 years; 54% female) identified in a registry of Korean hospitals between Jan. 1, 1994 and Dec. 31, 2013.

In the Journals

Low PSA levels may predict aggressive prostate cancer higher mortality risk

November 24, 2015
Very low PSA levels appeared associated with a greater risk for disease-specific death in men with high-grade prostate cancer, according to the results of a…
In the Journals

Personalized T-cell therapy yields promising outcomes in relapsed, refractory CLL

November 24, 2015
Chimeric antigen receptor T-cell therapy produced durable responses in patients with relapsed and refractory chronic lymphocytic leukemia, according to the results of a…
FDA News

FDA approves Portrazza for advanced squamous NSCLC

November 24, 2015
The FDA today approved necitumumab in combination with two forms of chemotherapy to treat patients with previously untreated advanced squamous non–small cell lung…
In the Journals

Self-managed anticoagulant therapy may benefit patients with heart valves

November 24, 2015
Self-management of oral anticoagulant therapy may improve standard care for patients with mechanical heart valves, according to study results.“Only small studies…
More News Headlines »

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Meeting News Coverage Video

VIDEO: Prognostic models can have ‘tremendous impact’ on long-term outcomes in CLL

November 20, 2015
More »

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Current Issues
View the Current Issue
HemOnc Today